Gilenya was first pill for multiple sclerosis which was approved in 2010 for relapsing-remitting MS. In 2018 it was approved for use in children and adolescents. Another study found that it was a viable option for patients switching from Tysabri.
People often eventually switch from Tysabri to a different drug because they became JC positive. The JC virus is often latent in the brain, but if you become JC positive, new lesions could form on your brain.
In the study involving children and adolescents, Gilenya appeared to have the same or better results than people on Tysabri after two years. Gilenya is another option for people with multiple sclerosis. Its major advantage is that it has nothing to do with injection needles, because it’s a pill.
I have been on Ocrevus for seven months now, and so far, so good. Ocrevus is an infusion that you get once every six months. I will stick with Ocrevus because I have noticed that I respond better to infusions rather than pills. I believe this is because with pills, you are introducing another variable between yourself and the MS, which is your digestive system.
My digestive system must do something to medicines which is not a good thing. The infusion, I believe, leads to more direct treatment of the MS without having to go through my digestive system first.
Other people may experience different results because we are all different. Gilenya is another treatment option for MS patients which they can choose in consultation with their medical doctor.
Find a path to treatment of MS which can be individualized with consultation with your medical doctor. See https://www.amazon.com/gp/aw/d/B07D7JBZ5L/ref=cm_cr_othr_mb_bdcrb_top?ie=UTF8